My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

42.70 -1.38 (-3.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Crinetics Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

January 22, 2025

Via Benzinga

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential ↗

December 16, 2024

Neurocrine's Crenessity receives FDA approval as a groundbreaking adjunctive treatment for classic CAH, offering a novel approach to hormone regulation.

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

What Analysts Are Saying About Crinetics Pharmaceuticals Stock ↗

September 27, 2024

Via Benzinga

A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals ↗

August 09, 2024

Via Benzinga

CRNX Stock Earnings: Crinetics Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗

August 08, 2024

CRNX stock results show that Crinetics Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals ↗

June 28, 2024

Via Benzinga

17 Analysts Have This To Say About Crinetics Pharmaceuticals ↗

June 04, 2024

Via Benzinga

18 Analysts Have This To Say About Crinetics Pharmaceuticals ↗

May 14, 2024

Via Benzinga

The Analyst Verdict: Crinetics Pharmaceuticals In The Eyes Of 6 Experts ↗

February 29, 2024

Via Benzinga

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details ↗

July 14, 2024

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 01, 2024

Via Benzinga

7 Biotech Stocks to Boost Your Portfolio to Peak Health ↗

June 26, 2024

With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.

Via InvestorPlace

Nvidia To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

June 04, 2024

Via Benzinga

Crinetics Pharmaceuticals: Q4 Earnings Insights ↗

February 28, 2024

Via Benzinga

Crinetics Pharmaceuticals Earnings Preview ↗

February 27, 2024

Via Benzinga

Analyst Scoreboard: 4 Ratings For Crinetics Pharmaceuticals ↗

December 19, 2023

Via Benzinga

Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday ↗

May 22, 2024

Via Benzinga

CRNX Stock Earnings: Crinetics Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

CRNX stock results show that Crinetics Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Endocrine Disease-Focused Crinetics Pharmaceuticals Stock Soars On Tuesday - Here's Why ↗

March 19, 2024

Crinetics Pharmaceuticals unveils PATHFNDR-2 Phase 3 results for paltusotine in acromegaly treatment. Statistically significant efficacy & safety, with plans for FDA submission in 2024.

Via Benzinga

National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday ↗

March 19, 2024

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.

Via Benzinga

Topics Stocks

8 Analysts Have This to Say About Crinetics Pharmaceuticals ↗

November 20, 2023

Via Benzinga

11 Analysts Have This to Say About Crinetics Pharmaceuticals ↗

October 24, 2023

Via Benzinga

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 19, 2024

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.

Via Benzinga

Biotech Stock Crinetics Jets Higher On Second Phase 3 Trial Win ↗

March 19, 2024

Biotech stock Crinetics Pharmaceuticals rocketed early Tuesday after solid trial results for its oral growth hormone treatment.

Via Investor's Business Daily

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday ↗

March 01, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Via Benzinga

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 28, 2023

Via Benzinga

Endocrine Diseases-Focused Crinetics Pharmaceuticals Highlights Favorable Initial Findings From Mid-Stage Study ↗

December 19, 2023

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) released initial findings from its ongoing open-label Phase 2 carcinoid syndrome (CS) study of paltusotine, an oral, once-daily investigational compound...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 09, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.